Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Times Interest Earned (2020 - 2024)

Gyre Therapeutics has reported Times Interest Earned over the past 9 years, most recently at $25.62 for Q1 2024.

  • Quarterly Times Interest Earned rose 147.23% to $25.62 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $51.31 through Dec 2024, up 149.07% year-over-year, with the annual reading at -$25.92 for FY2023, 486.95% down from the prior year.
  • Times Interest Earned was $25.62 for Q1 2024 at Gyre Therapeutics, up from $10.36 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $25.62 in Q1 2024 and troughed at -$2300.0 in Q3 2020.
  • The 3-year median for Times Interest Earned is -$183.23 (2020), against an average of -$660.21.
  • The largest YoY upside for Times Interest Earned was 147.23% in 2024 against a maximum downside of 147.23% in 2024.
  • A 3-year view of Times Interest Earned shows it stood at -$376.82 in 2020, then soared by 102.75% to $10.36 in 2023, then surged by 147.23% to $25.62 in 2024.
  • Per Business Quant, the three most recent readings for GYRE's Times Interest Earned are $25.62 (Q1 2024), $10.36 (Q1 2023), and -$376.82 (Q4 2020).